Fredrik Romi - Publications

2001 University of Bergen, Norway, Bergen, Hordaland, Norway 

26 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Hong Y, Skeie GO, Zisimopoulou P, Karagiorgou K, Tzartos SJ, Gao X, Yue YX, Romi F, Zhang X, Li HF, Gilhus NE. Retraction Note to: Juvenile-onset myasthenia gravis: autoantibody status, clinical characteristics and genetic polymorphisms. Journal of Neurology. PMID 30972499 DOI: 10.1007/s00415-019-09292-2  0.96
2018 Gilhus NE, Romi F, Hong Y, Skeie GO. Myasthenia gravis and infectious disease. Journal of Neurology. PMID 29372387 DOI: 10.1007/s00415-018-8751-9  0.96
2017 Romi F, Hong Y, Gilhus NE. Pathophysiology and immunological profile of myasthenia gravis and its subgroups. Current Opinion in Immunology. 49: 9-13. PMID 28780294 DOI: 10.1016/j.coi.2017.07.006  0.96
2017 Hong Y, Skeie GO, Zisimopoulou P, Karagiorgou K, Tzartos SJ, Gao X, Yue YX, Romi F, Zhang X, Li HF, Gilhus NE. Juvenile-onset myasthenia gravis: autoantibody status, clinical characteristics and genetic polymorphisms. Journal of Neurology. PMID 28364296 DOI: 10.1007/s00415-017-8478-z  0.96
2016 Hong Y, Li HF, Skeie GO, Romi F, Hao HJ, Zhang X, Gao X, Owe JF, Gilhus NE. Autoantibody profile and clinical characteristics in a cohort of Chinese adult myasthenia gravis patients. Journal of Neuroimmunology. 298: 51-7. PMID 27609275 DOI: 10.1016/j.jneuroim.2016.07.001  0.96
2016 Gilhus NE, Skeie GO, Romi F, Lazaridis K, Zisimopoulou P, Tzartos S. Myasthenia gravis - autoantibody characteristics and their implications for therapy. Nature Reviews. Neurology. 12: 259-68. PMID 27103470 DOI: 10.1038/nrneurol.2016.44  0.96
2014 Heldal AT, Eide GE, Romi F, Owe JF, Gilhus NE. Repeated acetylcholine receptor antibody-concentrations and association to clinical myasthenia gravis development. Plos One. 9: e114060. PMID 25464006 DOI: 10.1371/journal.pone.0114060  0.96
2012 Heldal AT, Eide GE, Gilhus NE, Romi F. Geographical distribution of a seropositive myasthenia gravis population. Muscle & Nerve. 45: 815-9. PMID 22581533 DOI: 10.1002/mus.23271  0.96
2012 Romi F, Helgeland G, Gilhus NE. Serum levels of matrix metalloproteinases: implications in clinical neurology. European Neurology. 67: 121-8. PMID 22262194 DOI: 10.1159/000334862  0.96
2012 Romi F, Suzuki S, Suzuki N, Petzold A, Plant GT, Gilhus NE. Anti-voltage-gated potassium channel Kv1.4 antibodies in myasthenia gravis. Journal of Neurology. 259: 1312-6. PMID 22167224 DOI: 10.1007/s00415-011-6344-y  0.96
2011 Gilhus NE, Owe JF, Hoff JM, Romi F, Skeie GO, Aarli JA. Myasthenia gravis: a review of available treatment approaches. Autoimmune Diseases. 2011: 847393. PMID 22007295 DOI: 10.4061/2011/847393  0.96
2011 Luckman SP, Gilhus NE, Romi F. Matrix metalloproteinase-3 in myasthenia gravis compared to other neurological disorders and healthy controls. Autoimmune Diseases. 2011: 151258. PMID 21826262 DOI: 10.4061/2011/151258  0.96
2011 Romi F, Helgeland G, Gilhus NE. Heat-shock proteins in clinical neurology. European Neurology. 66: 65-9. PMID 21757921 DOI: 10.1159/000329373  0.96
2011 Helgeland G, Petzold A, Luckman SP, Gilhus NE, Plant GT, Romi FR. Matrix metalloproteinases in myasthenia gravis. European Neurology. 65: 53-8. PMID 21212676 DOI: 10.1159/000322737  0.96
2010 Helgeland G, Petzold A, Hoff JM, Gilhus NE, Plant GT, Romi FR. Anti-Heat Shock Protein 70 antibody levels are increased in myasthenia gravis and Guillain-Barré syndrome. Journal of Neuroimmunology. 225: 180-3. PMID 20554026 DOI: 10.1016/j.jneuroim.2010.04.024  0.96
2010 Owe JF, Cvancarova M, Romi F, Gilhus NE. Extrathymic malignancies in thymoma patients with and without myasthenia gravis. Journal of the Neurological Sciences. 290: 66-9. PMID 20034637 DOI: 10.1016/j.jns.2009.11.006  0.96
2009 Heldal AT, Owe JF, Gilhus NE, Romi F. Seropositive myasthenia gravis: a nationwide epidemiologic study. Neurology. 73: 150-1. PMID 19597135 DOI: 10.1212/WNL.0b013e3181ad53c2  0.96
2008 Helgeland G, Luckman SP, Romi FR, Jonassen AK, Gilhus NE. Myasthenia gravis sera have no effect on cardiomyocytes in vitro. Journal of Neuroimmunology. 201: 74-9. PMID 18632164 DOI: 10.1016/j.jneuroim.2008.05.021  0.96
2008 Romi FR, Gilhus NE, Luckman SP. Serum matrix metalloproteinase-3 levels are elevated in myasthenia gravis. Journal of Neuroimmunology. 195: 96-9. PMID 18262287 DOI: 10.1016/j.jneuroim.2007.10.018  0.96
2005 Romi F, Skeie GO, Gilhus NE, Aarli JA. Striational antibodies in myasthenia gravis: reactivity and possible clinical significance. Archives of Neurology. 62: 442-6. PMID 15767509 DOI: 10.1001/archneur.62.3.442  0.96
2005 Romi F, Kristoffersen EK, Aarli JA, Gilhus NE. The role of complement in myasthenia gravis: serological evidence of complement consumption in vivo. Journal of Neuroimmunology. 158: 191-4. PMID 15589053 DOI: 10.1016/j.jneuroim.2004.08.002  0.96
2004 Romi F, Gilhus NE, Aarli JA. [Thymectomy and muscle antibodies in myasthenia gravis]. Tidsskrift For Den Norske Laegeforening : Tidsskrift For Praktisk Medicin, Ny Raekke. 124: 629-31. PMID 15004605  0.96
2003 Romi F, Gilhus NE, Varhaug JE, Myking A, Skeie GO, Aarli JA. Thymectomy and antimuscle antibodies in nonthymomatous myasthenia gravis. Annals of the New York Academy of Sciences. 998: 481-90. PMID 14592917  0.96
2003 Agius MA, Richman DP, Fairclough RH, Aarli J, Gilhus NE, Romi F. Three forms of immune myasthenia. Annals of the New York Academy of Sciences. 998: 453-6. PMID 14592914 DOI: 10.1196/annals.1254.059  0.96
2003 Skeie GO, Romi F, Aarli JA, Bentsen PT, Gilhus NE. Pathogenesis of myositis and myasthenia associated with titin and ryanodine receptor antibodies. Annals of the New York Academy of Sciences. 998: 343-50. PMID 14592894  0.96
2002 Romi F, Bø L, Skeie GO, Myking A, Aarli JA, Gilhus NE. Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules. Journal of Neuroimmunology. 128: 82-9. PMID 12098514  0.96
Show low-probability matches.